SESSION WATCH
THE BILL ITSELF

CS/CS/HB 309

Controlled Substances

VERSION H 309 c2 · BACK TO THE SUMMARY · OFFICIAL RECORD

underlined language is being added; struck language is being deleted. Line numbers are the Legislature's own — the same ones amendments cite.

1 A bill to be entitled
2 An act relating to controlled substances; amending s.
3 893.03, F.S.; excepting from the list of Schedule I
4 controlled substances certain xylazine animal drug
5 products approved by the United States Food and Drug
6 Administration and used for certain purposes; amending
7 s. 893.13, F.S.; providing criminal penalties and
8 requiring a mandatory minimum term of imprisonment if
9 a person sells, manufactures, or delivers or possesses
10 with intent to sell, manufacture, or deliver xylazine;
11 amending s. 893.135, F.S.; creating the offense of
12 trafficking in xylazine; providing criminal penalties
13 and requiring a mandatory minimum term of imprisonment
14 and fines based on the quantity of the controlled
15 substance involved in the offense; providing effective
16 dates.
18 Be It Enacted by the Legislature of the State of Florida:
20 Section 1. Effective July 1, 2026, paragraph (c) of
21 subsection (1) of section 893.03, Florida Statutes, is amended
22 to read:
23 893.03 Standards and schedules.—The substances enumerated
24 in this section are controlled by this chapter. The controlled
25 substances listed or to be listed in Schedules I, II, III, IV,
26 and V are included by whatever official, common, usual,
27 chemical, trade name, or class designated. The provisions of
28 this section shall not be construed to include within any of the
29 schedules contained in this section any excluded drugs listed
30 within the purview of 21 C.F.R. s. 1308.22, styled "Excluded
31 Substances"; 21 C.F.R. s. 1308.24, styled "Exempt Chemical
32 Preparations"; 21 C.F.R. s. 1308.32, styled "Exempted
33 Prescription Products"; or 21 C.F.R. s. 1308.34, styled "Exempt
34 Anabolic Steroid Products."
35 (1) SCHEDULE I.—A substance in Schedule I has a high
36 potential for abuse and has no currently accepted medical use in
37 treatment in the United States and in its use under medical
38 supervision does not meet accepted safety standards. The
39 following substances are controlled in Schedule I:
40 (c) Unless specifically excepted or unless listed in
41 another schedule, any material, compound, mixture, or
42 preparation that contains any quantity of the following
43 hallucinogenic substances or that contains any of their salts,
44 isomers, including optical, positional, or geometric isomers,
45 homologues, nitrogen-heterocyclic analogs, esters, ethers, and
46 salts of isomers, homologues, nitrogen-heterocyclic analogs,
47 esters, or ethers, if the existence of such salts, isomers, and
48 salts of isomers is possible within the specific chemical
49 designation or class description:
50 1. Alpha-Ethyltryptamine.
51 2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2-
52 oxazoline).
53 3. Aminorex (2-Amino-5-phenyl-2-oxazoline).
54 4. DOB (4-Bromo-2,5-dimethoxyamphetamine).
55 5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
56 6. Bufotenine.
57 7. Cannabis.
58 8. Cathinone.
59 9. DET (Diethyltryptamine).
60 10. 2,5-Dimethoxyamphetamine.
61 11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).
62 12. DMT (Dimethyltryptamine).
63 13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine
64 analog of phencyclidine).
65 14. JB-318 (N-Ethyl-3-piperidyl benzilate).
66 15. N-Ethylamphetamine.
67 16. Fenethylline.
68 17. 3,4-Methylenedioxy-N-hydroxyamphetamine.
69 18. Ibogaine.
70 19. LSD (Lysergic acid diethylamide).
71 20. Mescaline.
72 21. Methcathinone.
73 22. 5-Methoxy-3,4-methylenedioxyamphetamine.
74 23. PMA (4-Methoxyamphetamine).
75 24. PMMA (4-Methoxymethamphetamine).
76 25. DOM (4-Methyl-2,5-dimethoxyamphetamine).
77 26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
78 27. MDA (3,4-Methylenedioxyamphetamine).
79 28. JB-336 (N-Methyl-3-piperidyl benzilate).
80 29. N,N-Dimethylamphetamine.
81 30. Parahexyl.
82 31. Peyote.
83 32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine
84 analog of phencyclidine).
85 33. Psilocybin.
86 34. Psilocyn.
87 35. Salvia divinorum, except for any drug product approved
88 by the United States Food and Drug Administration which contains
89 Salvia divinorum or its isomers, esters, ethers, salts, and
90 salts of isomers, esters, and ethers, if the existence of such
91 isomers, esters, ethers, and salts is possible within the
92 specific chemical designation.
93 36. Salvinorin A, except for any drug product approved by
94 the United States Food and Drug Administration which contains
95 Salvinorin A or its isomers, esters, ethers, salts, and salts of
96 isomers, esters, and ethers, if the existence of such isomers,
97 esters, ethers, and salts is possible within the specific
98 chemical designation.
99 37. Xylazine, except for a xylazine animal drug product
100 approved by the United States Food and Drug Administration and
101 the use of which conforms to the approved application or is
102 authorized under 21 U.S.C. s. 360b(a)(4). The manufacture,
103 importation, distribution, prescribing, or sale of xylazine for
104 human use is not subject to this exception.
105 38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)
106 (Thiophene analog of phencyclidine).
107 39. 3,4,5-Trimethoxyamphetamine.
108 40. Methylone (3,4-Methylenedioxymethcathinone).
109 41. MDPV (3,4-Methylenedioxypyrovalerone).
110 42. Methylmethcathinone.
111 43. Methoxymethcathinone.
112 44. Fluoromethcathinone.
113 45. Methylethcathinone.
114 46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-
115 yl)phenol) and its dimethyloctyl (C8) homologue.
116 47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-
117 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-
118 ol].
119 48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
120 49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
121 50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-
122 naphthoyl)indole).
123 51. BZP (Benzylpiperazine).
124 52. Fluorophenylpiperazine.
125 53. Methylphenylpiperazine.
126 54. Chlorophenylpiperazine.
127 55. Methoxyphenylpiperazine.
128 56. DBZP (1,4-Dibenzylpiperazine).
129 57. TFMPP (Trifluoromethylphenylpiperazine).
130 58. MBDB (Methylbenzodioxolylbutanamine) or (3,4-
131 Methylenedioxy-N-methylbutanamine).
132 59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
133 60. 5-Hydroxy-N-methyltryptamine.
134 61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
135 62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
136 63. Methyltryptamine.
137 64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
138 65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
139 66. Tyramine (4-Hydroxyphenethylamine).
140 67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
141 68. DiPT (N,N-Diisopropyltryptamine).
142 69. DPT (N,N-Dipropyltryptamine).
143 70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
144 71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
145 72. DOI (4-Iodo-2,5-dimethoxyamphetamine).
146 73. DOC (4-Chloro-2,5-dimethoxyamphetamine).
147 74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
148 75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
149 76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
150 77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
151 78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
152 79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
153 80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
154 81. Butylone (3,4-Methylenedioxy-alpha-
155 methylaminobutyrophenone).
156 82. Ethcathinone.
157 83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
158 84. Naphyrone (Naphthylpyrovalerone).
159 85. Dimethylone (3,4-Methylenedioxy-N,N-
160 dimethylcathinone).
161 86. 3,4-Methylenedioxy-N,N-diethylcathinone.
162 87. 3,4-Methylenedioxy-propiophenone.
163 88. 3,4-Methylenedioxy-alpha-bromopropiophenone.
164 89. 3,4-Methylenedioxy-propiophenone-2-oxime.
165 90. 3,4-Methylenedioxy-N-acetylcathinone.
166 91. 3,4-Methylenedioxy-N-acetylmethcathinone.
167 92. 3,4-Methylenedioxy-N-acetylethcathinone.
168 93. Bromomethcathinone.
169 94. Buphedrone (alpha-Methylamino-butyrophenone).
170 95. Eutylone (3,4-Methylenedioxy-alpha-
171 ethylaminobutyrophenone).
172 96. Dimethylcathinone.
173 97. Dimethylmethcathinone.
174 98. Pentylone (3,4-Methylenedioxy-alpha-
175 methylaminovalerophenone).
176 99. MDPPP (3,4-Methylenedioxy-alpha-
177 pyrrolidinopropiophenone).
178 100. MDPBP (3,4-Methylenedioxy-alpha-
179 pyrrolidinobutyrophenone).
180 101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
181 102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).
182 103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
183 (Benocyclidine).
184 104. F-MABP (Fluoromethylaminobutyrophenone).
185 105. MeO-PBP (Methoxypyrrolidinobutyrophenone).
186 106. Et-PBP (Ethylpyrrolidinobutyrophenone).
187 107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
188 108. Me-EABP (Methylethylaminobutyrophenone).
189 109. Etizolam.
190 110. PPP (Pyrrolidinopropiophenone).
191 111. PBP (Pyrrolidinobutyrophenone).
192 112. PVP (Pyrrolidinovalerophenone) or
193 (Pyrrolidinopentiophenone).
194 113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).
195 114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
196 115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
197 116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
198 117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
199 118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
200 119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
201 120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
202 121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-
203 methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
204 122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
205 123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
206 124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
207 125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
208 126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
209 127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
210 128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
211 129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
212 130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-
213 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-
214 ol).
215 131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-
216 methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-
217 enyl] methanol).
218 132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1-
219 methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-
220 1,4-dione).
221 133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).
222 134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-
223 undecanamide).
224 135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-
225 undecanamide).
226 136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2-
227 methyloctan-2-yl)phenol).
228 137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
229 138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).
230 139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
231 140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2-
232 methoxyphenylacetyl)indole).
233 141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-
234 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
235 naphthalenylmethanone).
236 142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4-
237 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
238 naphthalenylmethanone).
239 143. Pentedrone (alpha-Methylaminovalerophenone).
240 144. Fluoroamphetamine.
241 145. Fluoromethamphetamine.
242 146. Methoxetamine.
243 147. Methiopropamine.
244 148. Methylbuphedrone (Methyl-alpha-
245 methylaminobutyrophenone).
246 149. APB ((2-Aminopropyl)benzofuran).
247 150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).
248 151. UR-144 (1-Pentyl-3-(2,2,3,3-
249 tetramethylcyclopropanoyl)indole).
250 152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-
251 tetramethylcyclopropanoyl)indole).
252 153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-
253 tetramethylcyclopropanoyl)indole).
254 154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-
255 carboxamide).
256 155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-
257 iodobenzoyl)indole).
258 156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-
259 carboxamide).
260 157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)-
261 cyclohexylcarbamate).
262 158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,
263 cyclohexyl ester).
264 159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1-
265 benzoxazin-4-one).
266 160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
267 161. 2C-H (2,5-Dimethoxyphenethylamine).
268 162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
269 163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
270 164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-
271 methoxybenzyl)]phenethylamine).
272 165. MDMA (3,4-Methylenedioxymethamphetamine).
273 166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
274 167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3-
275 carboxylate).
276 168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3-
277 carboxylate).
278 169. Fluoro AKB48 (N-Adamant-1-yl 1-
279 (fluoropentyl)indazole-3-carboxamide).
280 170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
281 pentylindazole-3-carboxamide).
282 171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
283 (4-fluorobenzyl)indazole-3-carboxamide).
284 172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-
285 1-pentylindazole-3-carboxamide).
286 173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-
287 yl)-1-(fluoropentyl)indole-3-carboxamide).
288 174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-
289 methoxybenzyl)]phenethylamine).
290 175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-
291 methoxybenzyl)]phenethylamine).
292 176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
293 (cyclohexylmethyl)indazole-3-carboxamide).
294 177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-
295 carboxylate).
296 178. Fluoro-NNEI (N-Naphthalen-1-yl 1-
297 (fluoropentyl)indole-3-carboxamide).
298 179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-
299 (fluoropentyl)indazole-3-carboxamide).
300 180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-
301 naphthoyl)indazole).
302 181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl-
303 1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
304 182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9-
305 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-
306 hexahydrobenzo[c]chromen-1-ol).
307 183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9-
308 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-
309 hexahydrobenzo[c]chromen-1-ol).
310 184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)-
311 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9
312 diol).
313 185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6-
314 dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a-
315 tetrahydro-6aH-benzo[c]chromen-1-ol).
316 186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl-
317 6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).
318 187. MAPB ((2-Methylaminopropyl)benzofuran).
319 188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).
320 189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).
321 190. Synthetic Cannabinoids.—Unless specifically excepted
322 or unless listed in another schedule or contained within a
323 pharmaceutical product approved by the United States Food and
324 Drug Administration, any material, compound, mixture, or
325 preparation that contains any quantity of a synthetic
326 cannabinoid found to be in any of the following chemical class
327 descriptions, or homologues, nitrogen-heterocyclic analogs,
328 isomers (including optical, positional, or geometric), esters,
329 ethers, salts, and salts of homologues, nitrogen-heterocyclic
330 analogs, isomers, esters, or ethers, whenever the existence of
331 such homologues, nitrogen-heterocyclic analogs, isomers, esters,
332 ethers, salts, and salts of isomers, esters, or ethers is
333 possible within the specific chemical class or designation.
334 Since nomenclature of these synthetically produced cannabinoids
335 is not internationally standardized and may continually evolve,
336 these structures or the compounds of these structures shall be
337 included under this subparagraph, regardless of their specific
338 numerical designation of atomic positions covered, if it can be
339 determined through a recognized method of scientific testing or
340 analysis that the substance contains properties that fit within
341 one or more of the following categories:
342 a. Tetrahydrocannabinols.—Any tetrahydrocannabinols
343 naturally contained in a plant of the genus Cannabis, the
344 synthetic equivalents of the substances contained in the plant
345 or in the resinous extracts of the genus Cannabis, or synthetic
346 substances, derivatives, and their isomers with similar chemical
347 structure and pharmacological activity, including, but not
348 limited to, Delta 9 tetrahydrocannabinols and their optical
349 isomers, Delta 8 tetrahydrocannabinols and their optical
350 isomers, Delta 6a,10a tetrahydrocannabinols and their optical
351 isomers, or any compound containing a tetrahydrobenzo[c]chromene
352 structure with substitution at either or both the 3-position or
353 9-position, with or without substitution at the 1-position with
354 hydroxyl or alkoxy groups, including, but not limited to:
355 (I) Tetrahydrocannabinol.
356 (II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-
357 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-
358 ol).
359 (III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-
360 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-
361 ol).
362 (IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-
363 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
364 (V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-
365 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
366 (VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan-
367 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
368 (VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-
369 (2,3-dimethylpentan-2-yl)-6a,7,10,10a-
370 tetrahydrobenzo[c]chromene).
371 (VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)-
372 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
373 (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl-
374 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
375 (X) Parahexyl.
376 b. Naphthoylindoles, Naphthoylindazoles,
377 Naphthoylcarbazoles, Naphthylmethylindoles,
378 Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any
379 compound containing a naphthoylindole, naphthoylindazole,
380 naphthoylcarbazole, naphthylmethylindole,
381 naphthylmethylindazole, or naphthylmethylcarbazole structure,
382 with or without substitution on the indole, indazole, or
383 carbazole ring to any extent, whether or not substituted on the
384 naphthyl ring to any extent, including, but not limited to:
385 (I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
386 (II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1-
387 naphthoyl)indole).
388 (III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
389 (IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).
390 (V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
391 (VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
392 (VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
393 (VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).
394 (IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).
395 (X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
396 (XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
397 (XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).
398 (XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
399 (XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1-
400 naphthoyl)indole).
401 (XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).
402 (XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
403 (XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1-
404 naphthoyl)indole).
405 (XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-
406 naphthoyl)indole).
407 (XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
408 (XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).
409 (XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).
410 (XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1-
411 naphthylmethyl]indole).
412 (XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1-
413 naphthoyl)indole).
414 (XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1-
415 naphthoyl)indole).
416 (XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-
417 naphthoyl)indole).
418 (XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
419 (XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).
420 (XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-
421 naphthoyl)indole).
422 (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
423 (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
424 (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1-
425 naphthoyl)indole).
426 (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1-
427 naphthoyl)indole).
428 (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1-
429 naphthoyl)indole).
430 (XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1-
431 naphthoyl)indole).
432 (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1-
433 naphthoyl)indole).
434 (XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).
435 (XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1-
436 naphthoyl)indazole).
437 (XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1-
438 naphthoyl)indole).
439 (XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1-
440 naphthoyl)indole).
441 (XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole).
442 (XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1-
443 naphthoyl)carbazole).
444 c. Naphthoylpyrroles.—Any compound containing a
445 naphthoylpyrrole structure, with or without substitution on the
446 pyrrole ring to any extent, whether or not substituted on the
447 naphthyl ring to any extent, including, but not limited to:
448 (I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).
449 (II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).
450 (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
451 (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
452 (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
453 (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1-
454 naphthoyl)pyrrole).
455 (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1-
456 naphthoyl)pyrrole).
457 (VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1-
458 naphthoyl)pyrrole).
459 (IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1-
460 naphthoyl)pyrrole).
461 (X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1-
462 naphthoyl)pyrrole).
463 d. Naphthylmethylenindenes.—Any compound containing a
464 naphthylmethylenindene structure, with or without substitution
465 at the 3-position of the indene ring to any extent, whether or
466 not substituted on the naphthyl ring to any extent, including,
467 but not limited to, JWH-176 (3-Pentyl-1-
468 (naphthylmethylene)indene).
469 e. Phenylacetylindoles and Phenylacetylindazoles.—Any
470 compound containing a phenylacetylindole or phenylacetylindazole
471 structure, with or without substitution on the indole or
472 indazole ring to any extent, whether or not substituted on the
473 phenyl ring to any extent, including, but not limited to:
474 (I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).
475 (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
476 (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
477 (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
478 (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
479 (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
480 (VII) Cannabipiperidiethanone.
481 (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2-
482 methoxyphenylacetyl)indole).
483 f. Cyclohexylphenols.—Any compound containing a
484 cyclohexylphenol structure, with or without substitution at the
485 5-position of the phenolic ring to any extent, whether or not
486 substituted on the cyclohexyl ring to any extent, including, but
487 not limited to:
488 (I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-
489 yl)phenol).
490 (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)
491 homologue).
492 (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2-
493 methyloctan-2-yl)phenol).
494 g. Benzoylindoles and Benzoylindazoles.—Any compound
495 containing a benzoylindole or benzoylindazole structure, with or
496 without substitution on the indole or indazole ring to any
497 extent, whether or not substituted on the phenyl ring to any
498 extent, including, but not limited to:
499 (I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).
500 (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
501 (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-
502 iodo-5-nitrobenzoyl)indole).
503 (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-
504 (4-methoxybenzoyl)indole).
505 (V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-
506 iodobenzoyl)indole).
507 (VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
508 (VII) RCS-4 C4 homologue (1-Butyl-3-(4-
509 methoxybenzoyl)indole).
510 (VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo-
511 3-(4-methoxybenzoyl)indole).
512 h. Tetramethylcyclopropanoylindoles and
513 Tetramethylcyclopropanoylindazoles.—Any compound containing a
514 tetramethylcyclopropanoylindole or
515 tetramethylcyclopropanoylindazole structure, with or without
516 substitution on the indole or indazole ring to any extent,
517 whether or not substituted on the tetramethylcyclopropyl group
518 to any extent, including, but not limited to:
519 (I) UR-144 (1-Pentyl-3-(2,2,3,3-
520 tetramethylcyclopropanoyl)indole).
521 (II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-
522 tetramethylcyclopropanoyl)indole).
523 (III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-
524 tetramethylcyclopropanoyl)indole).
525 (IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3-
526 tetramethylcyclopropanoyl)indole).
527 (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3-
528 tetramethylcyclopropanoyl)indole).
529 (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3-
530 tetramethylcyclopropanoyl)indole).
531 (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3-
532 tetramethylcyclopropanoyl)indole).
533 (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3-
534 tetramethylcyclopropanoyl)indazole).
535 (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3-
536 tetramethylcyclopropanoyl)indole).
537 (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3-
538 tetramethylcyclopropanoyl)indole).
539 i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole
540 carboxamides, and Adamantylindazole carboxamides.—Any compound
541 containing an adamantoyl indole, adamantoyl indazole, adamantyl
542 indole carboxamide, or adamantyl indazole carboxamide structure,
543 with or without substitution on the indole or indazole ring to
544 any extent, whether or not substituted on the adamantyl ring to
545 any extent, including, but not limited to:
546 (I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
547 (II) Fluoro AKB48 (N-Adamant-1-yl 1-
548 (fluoropentyl)indazole-3-carboxamide).
549 (III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-
550 carboxamide).
551 (IV) AM-1248 (1-(1-Methylpiperidine)methyl-3-(1-
552 adamantoyl)indole).
553 (V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).
554 (VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).
555 (VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1-
556 adamantoyl)indole).
557 j. Quinolinylindolecarboxylates,
558 Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,
559 and Quinolinylindazolecarboxamides.—Any compound containing a
560 quinolinylindole carboxylate, quinolinylindazole carboxylate,
561 isoquinolinylindole carboxylate, isoquinolinylindazole
562 carboxylate, quinolinylindole carboxamide, quinolinylindazole
563 carboxamide, isoquinolinylindole carboxamide, or
564 isoquinolinylindazole carboxamide structure, with or without
565 substitution on the indole or indazole ring to any extent,
566 whether or not substituted on the quinoline or isoquinoline ring
567 to any extent, including, but not limited to:
568 (I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
569 (II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3-
570 carboxylate).
571 (III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3-
572 carboxylate).
573 (IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-
574 carboxylate).
575 (V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).
576 (VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole-
577 3-carboxylate).
578 (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole-
579 3-carboxylate).
580 (VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).
581 (IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3-
582 carboxamide).
583 k. Naphthylindolecarboxylates and
584 Naphthylindazolecarboxylates.—Any compound containing a
585 naphthylindole carboxylate or naphthylindazole carboxylate
586 structure, with or without substitution on the indole or
587 indazole ring to any extent, whether or not substituted on the
588 naphthyl ring to any extent, including, but not limited to:
589 (I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3-
590 carboxylate).
591 (II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3-
592 carboxylate).
593 (III) Fluoro SDB-005 (1-Naphthalenyl 1-
594 (fluoropentyl)indazole-3-carboxylate).
595 (IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3-
596 carboxylate).
597 (V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3-
598 carboxylate).
599 l. Naphthylindole carboxamides and Naphthylindazole
600 carboxamides.—Any compound containing a naphthylindole
601 carboxamide or naphthylindazole carboxamide structure, with or
602 without substitution on the indole or indazole ring to any
603 extent, whether or not substituted on the naphthyl ring to any
604 extent, including, but not limited to:
605 (I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).
606 (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-
607 (fluoropentyl)indole-3-carboxamide).
608 (III) Chloro-NNEI (N-Naphthalen-1-yl 1-
609 (chloropentyl)indole-3-carboxamide).
610 (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3-
611 carboxamide).
612 (V) Fluoro MN-18 (N-Naphthalen-1-yl 1-
613 (fluoropentyl)indazole-3-carboxamide).
614 m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl
615 indazole carboxamides, Alkylcarbonyl indole carboxylates, and
616 Alkylcarbonyl indazole carboxylates.—Any compound containing an
617 alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,
618 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3-
619 phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an
620 indole carboxamide, indazole carboxamide, indole carboxylate, or
621 indazole carboxylate, with or without substitution on the indole
622 or indazole ring to any extent, whether or not substituted on
623 the alkylcarbonyl group to any extent, including, but not
624 limited to:
625 (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-
626 pentylindole-3-carboxamide).
627 (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-
628 yl)-1-(fluoropentyl)indole-3-carboxamide).
629 (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-
630 1-(fluoropentyl)indole-3-carboxamide).
631 (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
632 pentylindazole-3-carboxamide).
633 (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-
634 yl)-1-(fluoropentyl)indazole-3-carboxamide).
635 (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-
636 1-pentylindazole-3-carboxamide).
637 (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-
638 oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
639 (VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-
640 1-(4-fluorobenzyl)indazole-3-carboxamide).
641 (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-
642 yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
643 (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
644 (cyclohexylmethyl)indazole-3-carboxamide).
645 (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-
646 1-(cyclohexylmethyl)indazole-3-carboxamide).
647 (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-
648 yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
649 (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-
650 pentylindazole-3-carboxamide).
651 (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-
652 1-(fluoropentyl)indazole-3-carboxamide).
653 (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4-
654 fluorobenzyl)indazole-3-carboxamide).
655 (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-
656 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
657 (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-
658 oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
659 (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-
660 2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
661 (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-
662 fluoropentyl)indole-3-carboxamide).
663 (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-
664 fluoropentyl)indazole-3-carboxamide).
665 (XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-
666 (cyclohexylmethyl)indazole-3-carboxamide).
667 (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4-
668 fluorobenzyl)indazole-3-carboxamide).
669 (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-
670 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
671 n. Cumylindolecarboxamides and Cumylindazolecarboxamides.—
672 Any compound containing a N-(2-phenylpropan-2-yl) indole
673 carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide
674 structure, with or without substitution on the indole or
675 indazole ring to any extent, whether or not substituted on the
676 phenyl ring of the cumyl group to any extent, including, but not
677 limited to:
678 (I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3-
679 carboxamide).
680 (II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-
681 (fluoropentyl)indole-3-carboxamide).
682 o. Other Synthetic Cannabinoids.—Any material, compound,
683 mixture, or preparation that contains any quantity of a
684 Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:
685 (I) With or without modification or replacement of a
686 carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage
687 between either two core rings, or linkage between a core ring
688 and group structure, with or without the addition of a carbon or
689 replacement of a carbon;
690 (II) With or without replacement of a core ring or group
691 structure, whether or not substituted on the ring or group
692 structures to any extent; and
693 (III) Is a cannabinoid receptor agonist, unless
694 specifically excepted or unless listed in another schedule or
695 contained within a pharmaceutical product approved by the United
696 States Food and Drug Administration.
697 191. Substituted Cathinones.—Unless specifically excepted,
698 listed in another schedule, or contained within a pharmaceutical
699 product approved by the United States Food and Drug
700 Administration, any material, compound, mixture, or preparation,
701 including its salts, isomers, esters, or ethers, and salts of
702 isomers, esters, or ethers, whenever the existence of such salts
703 is possible within any of the following specific chemical
704 designations:
705 a. Any compound containing a 2-amino-1-phenyl-1-propanone
706 structure;
707 b. Any compound containing a 2-amino-1-naphthyl-1-
708 propanone structure; or
709 c. Any compound containing a 2-amino-1-thiophenyl-1-
710 propanone structure, whether or not the compound is further
711 modified:
712 (I) With or without substitution on the ring system to any
713 extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,
714 haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused
715 dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide
716 substituents;
717 (II) With or without substitution at the 3-propanone
718 position with an alkyl substituent or removal of the methyl
719 group at the 3-propanone position;
720 (III) With or without substitution at the 2-amino nitrogen
721 atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or
722 not further substituted in the ring system; or
723 (IV) With or without inclusion of the 2-amino nitrogen
724 atom in a cyclic structure, including, but not limited to:
725 (A) Methcathinone.
726 (B) Ethcathinone.
727 (C) Methylone (3,4-Methylenedioxymethcathinone).
728 (D) 2,3-Methylenedioxymethcathinone.
729 (E) MDPV (3,4-Methylenedioxypyrovalerone).
730 (F) Methylmethcathinone.
731 (G) Methoxymethcathinone.
732 (H) Fluoromethcathinone.
733 (I) Methylethcathinone.
734 (J) Butylone (3,4-Methylenedioxy-alpha-
735 methylaminobutyrophenone).
736 (K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
737 (L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).
738 (M) Naphyrone (Naphthylpyrovalerone).
739 (N) Bromomethcathinone.
740 (O) Buphedrone (alpha-Methylaminobutyrophenone).
741 (P) Eutylone (3,4-Methylenedioxy-alpha-
742 ethylaminobutyrophenone).
743 (Q) Dimethylcathinone.
744 (R) Dimethylmethcathinone.
745 (S) Pentylone (3,4-Methylenedioxy-alpha-
746 methylaminovalerophenone).
747 (T) Pentedrone (alpha-Methylaminovalerophenone).
748 (U) MDPPP (3,4-Methylenedioxy-alpha-
749 pyrrolidinopropiophenone).
750 (V) MDPBP (3,4-Methylenedioxy-alpha-
751 pyrrolidinobutyrophenone).
752 (W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).
753 (X) PPP (Pyrrolidinopropiophenone).
754 (Y) PVP (Pyrrolidinovalerophenone) or
755 (Pyrrolidinopentiophenone).
756 (Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
757 (AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).
758 (BB) F-MABP (Fluoromethylaminobutyrophenone).
759 (CC) Me-EABP (Methylethylaminobutyrophenone).
760 (DD) PBP (Pyrrolidinobutyrophenone).
761 (EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).
762 (FF) Et-PBP (Ethylpyrrolidinobutyrophenone).
763 (GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
764 (HH) Dimethylone (3,4-Methylenedioxy-N,N-
765 dimethylcathinone).
766 (II) 3,4-Methylenedioxy-N,N-diethylcathinone.
767 (JJ) 3,4-Methylenedioxy-N-acetylcathinone.
768 (KK) 3,4-Methylenedioxy-N-acetylmethcathinone.
769 (LL) 3,4-Methylenedioxy-N-acetylethcathinone.
770 (MM) Methylbuphedrone (Methyl-alpha-
771 methylaminobutyrophenone).
772 (NN) Methyl-alpha-methylaminohexanophenone.
773 (OO) N-Ethyl-N-methylcathinone.
774 (PP) PHP (Pyrrolidinohexanophenone).
775 (QQ) PV8 (Pyrrolidinoheptanophenone).
776 (RR) Chloromethcathinone.
777 (SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.
778 192. Substituted Phenethylamines.—Unless specifically
779 excepted or unless listed in another schedule, or contained
780 within a pharmaceutical product approved by the United States
781 Food and Drug Administration, any material, compound, mixture,
782 or preparation, including its salts, isomers, esters, or ethers,
783 and salts of isomers, esters, or ethers, whenever the existence
784 of such salts is possible within any of the following specific
785 chemical designations, any compound containing a phenethylamine
786 structure, without a beta-keto group, and without a benzyl group
787 attached to the amine group, whether or not the compound is
788 further modified with or without substitution on the phenyl ring
789 to any extent with alkyl, alkylthio, nitro, alkoxy, thio,
790 halide, fused alkylenedioxy, fused furan, fused benzofuran,
791 fused dihydrofuran, or fused tetrahydropyran substituents,
792 whether or not further substituted on a ring to any extent, with
793 or without substitution at the alpha or beta position by any
794 alkyl substituent, with or without substitution at the nitrogen
795 atom, and with or without inclusion of the 2-amino nitrogen atom
796 in a cyclic structure, including, but not limited to:
797 a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
798 b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
799 c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
800 d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
801 e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
802 f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
803 g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
804 h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
805 i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
806 j. 2C-H (2,5-Dimethoxyphenethylamine).
807 k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
808 l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
809 m. MDMA (3,4-Methylenedioxymethamphetamine).
810 n. MBDB (Methylbenzodioxolylbutanamine) or (3,4-
811 Methylenedioxy-N-methylbutanamine).
812 o. MDA (3,4-Methylenedioxyamphetamine).
813 p. 2,5-Dimethoxyamphetamine.
814 q. Fluoroamphetamine.
815 r. Fluoromethamphetamine.
816 s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
817 t. DOB (4-Bromo-2,5-dimethoxyamphetamine).
818 u. DOC (4-Chloro-2,5-dimethoxyamphetamine).
819 v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).
820 w. DOI (4-Iodo-2,5-dimethoxyamphetamine).
821 x. DOM (4-Methyl-2,5-dimethoxyamphetamine).
822 y. PMA (4-Methoxyamphetamine).
823 z. N-Ethylamphetamine.
824 aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.
825 bb. 5-Methoxy-3,4-methylenedioxyamphetamine.
826 cc. PMMA (4-Methoxymethamphetamine).
827 dd. N,N-Dimethylamphetamine.
828 ee. 3,4,5-Trimethoxyamphetamine.
829 ff. 4-APB (4-(2-Aminopropyl)benzofuran).
830 gg. 5-APB (5-(2-Aminopropyl)benzofuran).
831 hh. 6-APB (6-(2-Aminopropyl)benzofuran).
832 ii. 7-APB (7-(2-Aminopropyl)benzofuran).
833 jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).
834 kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).
835 ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).
836 mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).
837 nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).
838 oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).
839 pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).
840 qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).
841 rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).
842 ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3-
843 dihydrobenzofuran),
845 which does not include phenethylamine, mescaline as described in
846 subparagraph 20., substituted cathinones as described in
847 subparagraph 191., N-Benzyl phenethylamine compounds as
848 described in subparagraph 193., or methamphetamine as described
849 in subparagraph (2)(c)5.
850 193. N-Benzyl Phenethylamine Compounds.—Unless
851 specifically excepted or unless listed in another schedule, or
852 contained within a pharmaceutical product approved by the United
853 States Food and Drug Administration, any material, compound,
854 mixture, or preparation, including its salts, isomers, esters,
855 or ethers, and salts of isomers, esters, or ethers, whenever the
856 existence of such salts is possible within any of the following
857 specific chemical designations, any compound containing a
858 phenethylamine structure without a beta-keto group, with
859 substitution on the nitrogen atom of the amino group with a
860 benzyl substituent, with or without substitution on the phenyl
861 or benzyl ring to any extent with alkyl, alkoxy, thio,
862 alkylthio, halide, fused alkylenedioxy, fused furan, fused
863 benzofuran, or fused tetrahydropyran substituents, whether or
864 not further substituted on a ring to any extent, with or without
865 substitution at the alpha position by any alkyl substituent,
866 including, but not limited to:
867 a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-
868 methoxybenzyl)]phenethylamine).
869 b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2-
870 hydroxybenzyl)]phenethylamine).
871 c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2-
872 fluorobenzyl)]phenethylamine).
873 d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3-
874 methylenedioxybenzyl)]phenethylamine).
875 e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-
876 methoxybenzyl)]phenethylamine).
877 f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2-
878 hydroxybenzyl)]phenethylamine).
879 g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2-
880 fluorobenzyl)]phenethylamine).
881 h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3-
882 methylenedioxybenzyl)]phenethylamine).
883 i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2-
884 methoxybenzyl)]phenethylamine).
885 j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2-
886 methoxybenzyl)]phenethylamine).
887 k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2-
888 methoxybenzyl)]phenethylamine).
889 l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-
890 methoxybenzyl)]phenethylamine).
891 m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2-
892 hydroxybenzyl)]phenethylamine).
893 n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2-
894 fluorobenzyl)]phenethylamine).
895 o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3-
896 methylenedioxybenzyl)]phenethylamine).
897 p. 25H-NBOMe (2,5-Dimethoxy-[N-(2-
898 methoxybenzyl)]phenethylamine).
899 q. 25H-NBOH (2,5-Dimethoxy-[N-(2-
900 hydroxybenzyl)]phenethylamine).
901 r. 25H-NBF (2,5-Dimethoxy-[N-(2-
902 fluorobenzyl)]phenethylamine).
903 s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2-
904 methoxybenzyl)]phenethylamine),
906 which does not include substituted cathinones as described in
907 subparagraph 191.
908 194. Substituted Tryptamines.—Unless specifically excepted
909 or unless listed in another schedule, or contained within a
910 pharmaceutical product approved by the United States Food and
911 Drug Administration, any material, compound, mixture, or
912 preparation containing a 2-(1H-indol-3-yl)ethanamine, for
913 example tryptamine, structure with or without mono- or di-
914 substitution of the amine nitrogen with alkyl or alkenyl groups,
915 or by inclusion of the amino nitrogen atom in a cyclic
916 structure, whether or not substituted at the alpha position with
917 an alkyl group, whether or not substituted on the indole ring to
918 any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy
919 groups, including, but not limited to:
920 a. Alpha-Ethyltryptamine.
921 b. Bufotenine.
922 c. DET (Diethyltryptamine).
923 d. DMT (Dimethyltryptamine).
924 e. MET (N-Methyl-N-ethyltryptamine).
925 f. DALT (N,N-Diallyltryptamine).
926 g. EiPT (N-Ethyl-N-isopropyltryptamine).
927 h. MiPT (N-Methyl-N-isopropyltryptamine).
928 i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
929 j. 5-Hydroxy-N-methyltryptamine.
930 k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
931 l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
932 m. Methyltryptamine.
933 n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
934 o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
935 p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
936 q. DiPT (N,N-Diisopropyltryptamine).
937 r. DPT (N,N-Dipropyltryptamine).
938 s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
939 t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
940 u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).
941 v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).
942 w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).
943 x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).
944 y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N-
945 isopropyltryptamine).
946 z. Methyl-alpha-ethyltryptamine.
947 aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),
949 which does not include tryptamine, psilocyn as described in
950 subparagraph 34., or psilocybin as described in subparagraph 33.
951 195. Substituted Phenylcyclohexylamines.—Unless
952 specifically excepted or unless listed in another schedule, or
953 contained within a pharmaceutical product approved by the United
954 States Food and Drug Administration, any material, compound,
955 mixture, or preparation containing a phenylcyclohexylamine
956 structure, with or without any substitution on the phenyl ring,
957 any substitution on the cyclohexyl ring, any replacement of the
958 phenyl ring with a thiophenyl or benzothiophenyl ring, with or
959 without substitution on the amine with alkyl, dialkyl, or alkoxy
960 substituents, inclusion of the nitrogen in a cyclic structure,
961 or any combination of the above, including, but not limited to:
962 a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
963 (Benocyclidine).
964 b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog
965 of phencyclidine).
966 c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine
967 analog of phencyclidine).
968 d. PCPr (Phenylcyclohexylpropylamine).
969 e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene
970 analog of phencyclidine).
971 f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).
972 g. PCMPA (Phenylcyclohexyl(methoxypropylamine)).
973 h. Methoxetamine.
974 i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).
975 j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).
976 k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).
977 l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).
978 m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).
979 n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).
980 o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).
981 p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).
982 q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).
983 r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).
984 196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2-
985 piperidinylidene]-benzenesulfonamide.
986 197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-
987 piperidinylidene]-benzenesulfonamide.
988 198. AH-7921, 3,4-dichloro-N-[[1-
989 (dimethylamino)cyclohexyl]methyl]-benzamide.
990 199. U47700, trans-3,4-dichloro-N-[2-
991 (dimethylamino)cyclohexyl]-N-methyl-benzamide.
992 200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,
993 dihydrochloride.
994 Section 2. Paragraph (i) of subsection (1) of section
995 893.13, Florida Statutes, is amended to read:
996 893.13 Prohibited acts; penalties.—
997 (1)
998 (i) Except as authorized by this chapter, a person commits
999 a felony of the first degree, punishable as provided in s.
1000 775.082, s. 775.083, or s. 775.084, and must be sentenced to a
1001 mandatory minimum term of imprisonment of 3 years, if:
1002 1. The person sells, manufactures, or delivers, or
1003 possesses with intent to sell, manufacture, or deliver, any of
1004 the following:
1005 a. Alfentanil, as described in s. 893.03(2)(b)1.;
1006 b. Carfentanil, as described in s. 893.03(2)(b)6.;
1007 c. Fentanyl, as described in s. 893.03(2)(b)9.;
1008 d. Sufentanil, as described in s. 893.03(2)(b)30.;
1009 e. A fentanyl derivative, as described in s.
1010 893.03(1)(a)63.;
1011 f. Xylazine, as described in s. 893.03(1)(c)37.;
1012 g.f. A controlled substance analog, as described in s.
1013 893.0356, of any substance described in sub-subparagraphs a.-f.
1014 sub-subparagraphs a.-e.; or
1015 h.g. A mixture containing any substance described in sub-
1016 subparagraphs a.-g. sub-subparagraphs a.-f.; and
1017 2. The substance or mixture listed in subparagraph 1. is
1018 in a form that resembles, or is mixed, granulated, absorbed,
1019 spray-dried, or aerosolized as or onto, coated on, in whole or
1020 in part, or solubilized with or into, a product, when such
1021 product or its packaging further has at least one of the
1022 following attributes:
1023 a. Resembles the trade dress of a branded food product,
1024 consumer food product, or logo food product;
1025 b. Incorporates an actual or fake registered copyright,
1026 service mark, or trademark;
1027 c. Resembles candy, cereal, a gummy, a vitamin, or a
1028 chewable product, such as a gum or gelatin-based product; or
1029 d. Contains a cartoon character imprint. Section 3. Paragraph (c) of subsection (1) of section
1031 893.135, Florida Statutes, is amended to read:
1032 893.135 Trafficking; mandatory sentences; suspension or
1033 reduction of sentences; conspiracy to engage in trafficking.—
1034 (1) Except as authorized in this chapter or in chapter 499
1035 and notwithstanding the provisions of s. 893.13:
1036 (c)1. A person who knowingly sells, purchases,
1037 manufactures, delivers, or brings into this state, or who is
1038 knowingly in actual or constructive possession of, 4 grams or
1039 more of any morphine, opium, hydromorphone, or any salt,
1040 derivative, isomer, or salt of an isomer thereof, including
1041 heroin, as described in s. 893.03(1)(b), (2)(a), (3)(c)3., or
1042 (3)(c)4., or 4 grams or more of any mixture containing any such
1043 substance, but less than 30 kilograms of such substance or
1044 mixture, commits a felony of the first degree, which felony
1045 shall be known as "trafficking in illegal drugs," punishable as
1046 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1047 quantity involved:
1048 a. Is 4 grams or more, but less than 14 grams, such person
1049 shall be sentenced to a mandatory minimum term of imprisonment
1050 of 3 years and shall be ordered to pay a fine of $50,000.
1051 b. Is 14 grams or more, but less than 28 grams, such
1052 person shall be sentenced to a mandatory minimum term of
1053 imprisonment of 15 years and shall be ordered to pay a fine of
1054 $100,000.
1055 c. Is 28 grams or more, but less than 30 kilograms, such
1056 person shall be sentenced to a mandatory minimum term of
1057 imprisonment of 25 years and shall be ordered to pay a fine of
1058 $500,000.
1059 2. A person who knowingly sells, purchases, manufactures,
1060 delivers, or brings into this state, or who is knowingly in
1061 actual or constructive possession of, 28 grams or more of
1062 hydrocodone, as described in s. 893.03(2)(a)1.k., codeine, as
1063 described in s. 893.03(2)(a)1.g., or any salt thereof, or 28
1064 grams or more of any mixture containing any such substance,
1065 commits a felony of the first degree, which felony shall be
1066 known as "trafficking in hydrocodone," punishable as provided in
1067 s. 775.082, s. 775.083, or s. 775.084. If the quantity involved:
1068 a. Is 28 grams or more, but less than 50 grams, such
1069 person shall be sentenced to a mandatory minimum term of
1070 imprisonment of 3 years and shall be ordered to pay a fine of
1071 $50,000.
1072 b. Is 50 grams or more, but less than 100 grams, such
1073 person shall be sentenced to a mandatory minimum term of
1074 imprisonment of 7 years and shall be ordered to pay a fine of
1075 $100,000.
1076 c. Is 100 grams or more, but less than 300 grams, such
1077 person shall be sentenced to a mandatory minimum term of
1078 imprisonment of 15 years and shall be ordered to pay a fine of
1079 $500,000.
1080 d. Is 300 grams or more, but less than 30 kilograms, such
1081 person shall be sentenced to a mandatory minimum term of
1082 imprisonment of 25 years and shall be ordered to pay a fine of
1083 $750,000.
1084 3. A person who knowingly sells, purchases, manufactures,
1085 delivers, or brings into this state, or who is knowingly in
1086 actual or constructive possession of, 7 grams or more of
1087 oxycodone, as described in s. 893.03(2)(a)1.q., or any salt
1088 thereof, or 7 grams or more of any mixture containing any such
1089 substance, commits a felony of the first degree, which felony
1090 shall be known as "trafficking in oxycodone," punishable as
1091 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1092 quantity involved:
1093 a. Is 7 grams or more, but less than 14 grams, such person
1094 shall be sentenced to a mandatory minimum term of imprisonment
1095 of 3 years and shall be ordered to pay a fine of $50,000.
1096 b. Is 14 grams or more, but less than 25 grams, such
1097 person shall be sentenced to a mandatory minimum term of
1098 imprisonment of 7 years and shall be ordered to pay a fine of
1099 $100,000.
1100 c. Is 25 grams or more, but less than 100 grams, such
1101 person shall be sentenced to a mandatory minimum term of
1102 imprisonment of 15 years and shall be ordered to pay a fine of
1103 $500,000.
1104 d. Is 100 grams or more, but less than 30 kilograms, such
1105 person shall be sentenced to a mandatory minimum term of
1106 imprisonment of 25 years and shall be ordered to pay a fine of
1107 $750,000.
1108 4.a. A person who knowingly sells, purchases,
1109 manufactures, delivers, or brings into this state, or who is
1110 knowingly in actual or constructive possession of, 4 grams or
1111 more of:
1112 (I) Alfentanil, as described in s. 893.03(2)(b)1.;
1113 (II) Carfentanil, as described in s. 893.03(2)(b)6.;
1114 (III) Fentanyl, as described in s. 893.03(2)(b)9.;
1115 (IV) Sufentanil, as described in s. 893.03(2)(b)30.;
1116 (V) A fentanyl derivative, as described in s.
1117 893.03(1)(a)63.;
1118 (VI) A controlled substance analog, as described in s.
1119 893.0356, of any substance described in sub-sub-subparagraphs
1120 (I)-(V); or
1121 (VII) A mixture containing any substance described in sub-
1122 sub-subparagraphs (I)-(VI),
1124 commits a felony of the first degree, which felony shall be
1125 known as "trafficking in dangerous fentanyl or fentanyl
1126 analogues," punishable as provided in s. 775.082, s. 775.083, or
1127 s. 775.084.
1128 b. If the quantity involved under sub-subparagraph a.:
1129 (I) Is 4 grams or more, but less than 14 grams, such
1130 person shall be sentenced to a mandatory minimum term of
1131 imprisonment of 7 years, and shall be ordered to pay a fine of
1132 $50,000.
1133 (II) Is 14 grams or more, but less than 28 grams, such
1134 person shall be sentenced to a mandatory minimum term of
1135 imprisonment of 20 years, and shall be ordered to pay a fine of
1136 $100,000.
1137 (III) Is 28 grams or more, such person shall be sentenced
1138 to a mandatory minimum term of imprisonment of 25 years, and
1139 shall be ordered to pay a fine of $500,000.
1140 c. A person 18 years of age or older who violates sub-
1141 subparagraph a. by knowingly selling or delivering to a minor at
1142 least 4 grams of a substance or mixture listed in sub-
1143 subparagraph a. shall be sentenced to a mandatory minimum term
1144 of not less than 25 years and not exceeding life imprisonment,
1145 and shall be ordered to pay a fine of $1 million if the
1146 substance or mixture listed in sub-subparagraph a. is in a form
1147 that resembles, or is mixed, granulated, absorbed, spray-dried,
1148 or aerosolized as or onto, coated on, in whole or in part, or
1149 solubilized with or into, a product, when such product or its
1150 packaging further has at least one of the following attributes:
1151 (I) Resembles the trade dress of a branded food product,
1152 consumer food product, or logo food product;
1153 (II) Incorporates an actual or fake registered copyright,
1154 service mark, or trademark;
1155 (III) Resembles candy, cereal, a gummy, a vitamin, or a
1156 chewable product, such as a gum or gelatin-based product; or
1157 (IV) Contains a cartoon character imprint.
1158 5. A person who knowingly sells, purchases, manufactures,
1159 delivers, or brings into this state, or who is knowingly in
1160 actual or constructive possession of, 30 kilograms or more of
1161 any morphine, opium, oxycodone, hydrocodone, codeine,
1162 hydromorphone, or any salt, derivative, isomer, or salt of an
1163 isomer thereof, including heroin, as described in s.
1164 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 30 kilograms or
1165 more of any mixture containing any such substance, commits the
1166 first degree felony of trafficking in illegal drugs. A person
1167 who has been convicted of the first degree felony of trafficking
1168 in illegal drugs under this subparagraph shall be punished by
1169 life imprisonment and is ineligible for any form of
1170 discretionary early release except pardon or executive clemency
1171 or conditional medical release under s. 947.149. However, if the
1172 court determines that, in addition to committing any act
1173 specified in this paragraph:
1174 a. The person intentionally killed an individual or
1175 counseled, commanded, induced, procured, or caused the
1176 intentional killing of an individual and such killing was the
1177 result; or
1178 b. The person's conduct in committing that act led to a
1179 natural, though not inevitable, lethal result,
1181 such person commits the capital felony of trafficking in illegal
1182 drugs, punishable as provided in ss. 775.082 and 921.142. A
1183 person sentenced for a capital felony under this paragraph shall
1184 also be sentenced to pay the maximum fine provided under
1185 subparagraph 1.
1186 6. A person who knowingly brings into this state 60
1187 kilograms or more of any morphine, opium, oxycodone,
1188 hydrocodone, codeine, hydromorphone, or any salt, derivative,
1189 isomer, or salt of an isomer thereof, including heroin, as
1190 described in s. 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or
1191 60 kilograms or more of any mixture containing any such
1192 substance, and who knows that the probable result of such
1193 importation would be the death of a person, commits capital
1194 importation of illegal drugs, a capital felony punishable as
1195 provided in ss. 775.082 and 921.142. A person sentenced for a
1196 capital felony under this paragraph shall also be sentenced to
1197 pay the maximum fine provided under subparagraph 1.
1198 7. A person who knowingly sells, purchases, manufactures,
1199 delivers, or brings into this state, or who is knowingly in
1200 actual or constructive possession of, 28 grams or more of
1201 xylazine, as described in s. 893.03(1)(c)37., or any salt
1202 thereof, or 28 grams or more of any mixture containing any such
1203 substance, commits a felony of the first degree, which felony
1204 shall be known as "trafficking in xylazine," punishable as
1205 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1206 quantity involved:
1207 a. Is 28 grams or more, but less than 100 grams, such
1208 person shall be sentenced to a mandatory minimum term of
1209 imprisonment of 3 years and shall be ordered to pay a fine of
1210 $50,000.
1211 b. Is 100 grams or more, but less than 200 grams, such
1212 person shall be sentenced to a mandatory minimum term of
1213 imprisonment of 7 years and shall be ordered to pay a fine of
1214 $100,000.
1215 c. Is 200 grams or more, such person shall be sentenced to
1216 a mandatory minimum term of imprisonment of 25 years and shall
1217 be ordered to pay a fine of $500,000.
1218 Section 4. Except as otherwise expressly provided in this
1219 act and except for this section, which shall take effect upon
1220 this act becoming a law, this act shall take effect October 1,
1221 2026.